Correlation Between Cyteir Therapeutics and Monte Rosa

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Cyteir Therapeutics and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and Monte Rosa.

Diversification Opportunities for Cyteir Therapeutics and Monte Rosa

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Cyteir and Monte is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and Monte Rosa go up and down completely randomly.

Pair Corralation between Cyteir Therapeutics and Monte Rosa

If you would invest  580.00  in Monte Rosa Therapeutics on March 18, 2024 and sell it today you would earn a total of  125.00  from holding Monte Rosa Therapeutics or generate 21.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy2.78%
ValuesDaily Returns

Cyteir Therapeutics  vs.  Monte Rosa Therapeutics

 Performance 
       Timeline  
Cyteir Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cyteir Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cyteir Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Monte Rosa Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cyteir Therapeutics and Monte Rosa Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyteir Therapeutics and Monte Rosa

The main advantage of trading using opposite Cyteir Therapeutics and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.
The idea behind Cyteir Therapeutics and Monte Rosa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments